uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
24.88
+0.37
(+1.51%)
Pre-Market: 08:38
uniQure Max Drawdown (5Y) : 94.93% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 94.93% |
| July 31, 2026 | 94.93% |
| June 30, 2026 | 94.93% |
| May 31, 2026 | 94.93% |
| April 30, 2026 | 94.93% |
| March 31, 2026 | 94.93% |
| February 28, 2026 | 94.93% |
| January 31, 2026 | 94.93% |
| December 31, 2025 | 94.93% |
| November 30, 2025 | 94.93% |
| October 31, 2025 | 94.93% |
| September 30, 2025 | 94.93% |
| August 31, 2025 | 94.93% |
| July 31, 2025 | 94.93% |
| June 30, 2025 | 94.93% |
| May 31, 2025 | 94.93% |
| April 30, 2025 | 94.93% |
| March 31, 2025 | 94.93% |
| February 28, 2025 | 94.93% |
| January 31, 2025 | 94.93% |
| December 31, 2024 | 94.93% |
| November 30, 2024 | 94.93% |
| October 31, 2024 | 94.93% |
| September 30, 2024 | 94.93% |
| August 31, 2024 | 94.93% |
| Date | Value |
|---|---|
| July 31, 2024 | 94.93% |
| June 30, 2024 | 94.66% |
| May 31, 2024 | 94.66% |
| April 30, 2024 | 94.66% |
| March 31, 2024 | 94.14% |
| February 29, 2024 | 93.56% |
| January 31, 2024 | 93.28% |
| December 31, 2023 | 93.15% |
| November 30, 2023 | 93.15% |
| October 31, 2023 | 93.15% |
| September 30, 2023 | 91.84% |
| August 31, 2023 | 89.88% |
| July 31, 2023 | 88.44% |
| June 30, 2023 | 86.47% |
| May 31, 2023 | 84.00% |
| April 30, 2023 | 84.00% |
| March 31, 2023 | 84.00% |
| February 28, 2023 | 84.00% |
| January 31, 2023 | 84.00% |
| December 31, 2022 | 84.00% |
| November 30, 2022 | 84.00% |
| October 31, 2022 | 84.00% |
| September 30, 2022 | 84.00% |
| August 31, 2022 | 84.00% |
| July 31, 2022 | 84.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Kymera Therapeutics, Inc. | 87.51% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Twist Bioscience Corp. | 94.48% |
| GRAIL, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -1.351 |
| Beta (5Y) | 0.9422 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 166.6% |
| Historical Sharpe Ratio (5Y) | 0.0432 |
| Historical Sortino (5Y) | 0.1677 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.05% |